Cover Image
市場調查報告書

正常眼壓青光眼:全球臨床實驗趨勢

Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339390
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
正常眼壓青光眼:全球臨床實驗趨勢 Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 57 Pages
簡介

正常眼壓青光眼是儘管眼壓處於正常範圍但仍引起青光眼性視神經障礙的開放性青光眼。

本報告提供正常眼壓青光眼臨床實驗相關之最新趨勢分析,提供您各地區的臨床實驗數量,臨床實驗的各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 正常眼壓青光眼
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上正常眼壓青光眼的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上正常眼壓青光眼的比例

各階段臨床實驗數量

各進展狀況臨床實驗數量

臨床實驗的目標的達成情形

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

正常眼壓青光眼治療藥臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • 參天製藥
    • 日本眼科用藥研究所
    • Merck & Co., Inc.
    • 興和
    • 科研製藥
  • 有代表性的研究機關·醫院臨床實驗概要
    • MIzoguchi Eye Clinic
    • Chinese University of Hong Kong
    • 金澤大學附屬醫院
    • Seoul National University Hospital
    • The Catholic University of Korea
    • 東北大學
    • University of Erlangen-Nurnberg

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2793CTIDB

GlobalData's clinical trial report, "Normal-Tension Glaucoma Global Clinical Trials Review, H2, 2015" provides an overview of Normal-Tension Glaucoma clinical trials scenario. This report provides top line data relating to the clinical trials on Normal-Tension Glaucoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Normal-Tension Glaucoma
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
  • Clinical Trials by G7 Countries: Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Normal-Tension Glaucoma Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Santen Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Santen Pharmaceutical Co., Ltd.
      • Nitten Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Nitten Pharmaceutical Co., Ltd.
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Kowa Company, Ltd.
      • Clinical Trial Overview of Kowa Company, Ltd.
      • Kaken Pharmaceutical Co., Ltd.
      • Clinical Trial Overview of Kaken Pharmaceutical Co., Ltd.
    • Clinical Trial Overview of Top Institutes / Government
      • MIzoguchi Eye Clinic
      • Clinical Trial Overview of MIzoguchi Eye Clinic
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Kanazawa University Hospital
      • Clinical Trial Overview of Kanazawa University Hospital
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • The Catholic University of Korea
      • Clinical Trial Overview of The Catholic University of Korea
      • Tohoku University
      • Clinical Trial Overview of Tohoku University
      • University of Erlangen-Nurnberg
      • Clinical Trial Overview of University of Erlangen-Nurnberg
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Region, 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Europe, Top Countries, 2015*
  • Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Normal-Tension Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Santen Pharmaceutical Co., Ltd., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Nitten Pharmaceutical Co., Ltd., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaken Pharmaceutical Co., Ltd., 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by MIzoguchi Eye Clinic, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kanazawa University Hospital, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Catholic University of Korea, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Tohoku University, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Erlangen-Nurnberg, 2015*

List of Figures

  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Normal-Tension Glaucoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Normal-Tension Glaucoma to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Normal-Tension Glaucoma Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Normal-Tension Glaucoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Normal-Tension Glaucoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top